Loading clinical trials...
Loading clinical trials...
Clinical Equivalency Study of Two Formulations of Budesonide Inhalation Aerosol
Conditions
Interventions
Budiair® 200ug/puff inhalation aerosol
budesonide 200ug/puff inhalation aerosol
Locations
2
China
Wuxi People's Hospital
Wuxi, Jiangsu, China
Lunan Better Pharmaceutical Co., Ltd.
Linyi, Shandong, China
Start Date
December 30, 2024
Primary Completion Date
January 20, 2025
Completion Date
January 20, 2025
Last Updated
April 11, 2025
NCT06969963
NCT06600282
Lead Sponsor
Lunan Better Pharmaceutical Co., LTD.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions